These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 24366007

  • 1. Nutlin-3 induces HO-1 expression by activating JNK in a transcription-independent manner of p53.
    Choe YJ, Lee SY, Ko KW, Shin SJ, Kim HS.
    Int J Oncol; 2014 Mar; 44(3):761-8. PubMed ID: 24366007
    [Abstract] [Full Text] [Related]

  • 2. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
    Lee SY, Shin SJ, Kim HS.
    Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
    [Abstract] [Full Text] [Related]

  • 3. Nutlin-3 induces BCL2A1 expression by activating ELK1 through the mitochondrial p53-ROS-ERK1/2 pathway.
    Lee SY, Choi HC, Choe YJ, Shin SJ, Lee SH, Kim HS.
    Int J Oncol; 2014 Aug; 45(2):675-82. PubMed ID: 24867259
    [Abstract] [Full Text] [Related]

  • 4. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
    Lau LM, Nugent JK, Zhao X, Irwin MS.
    Oncogene; 2008 Feb 07; 27(7):997-1003. PubMed ID: 17700533
    [Abstract] [Full Text] [Related]

  • 5. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
    Kitagawa M, Aonuma M, Lee SH, Fukutake S, McCormick F.
    Oncogene; 2008 Sep 11; 27(40):5303-14. PubMed ID: 18521084
    [Abstract] [Full Text] [Related]

  • 6. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
    Ambrosini G, Sambol EB, Carvajal D, Vassilev LT, Singer S, Schwartz GK.
    Oncogene; 2007 May 24; 26(24):3473-81. PubMed ID: 17146434
    [Abstract] [Full Text] [Related]

  • 7. Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma: evidence for p53-transcription-dependent and -independent pathways.
    Saha MN, Jiang H, Chang H.
    Cancer Biol Ther; 2010 Sep 15; 10(6):567-78. PubMed ID: 20595817
    [Abstract] [Full Text] [Related]

  • 8. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
    Kang YH, Lee SJ.
    J Cell Physiol; 2008 Oct 15; 217(1):23-33. PubMed ID: 18412143
    [Abstract] [Full Text] [Related]

  • 9. P53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK.
    Fan S, Qi M, Yu Y, Li L, Yao G, Tashiro S, Onodera S, Ikejima T.
    Free Radic Res; 2012 Mar 15; 46(3):310-9. PubMed ID: 22283740
    [Abstract] [Full Text] [Related]

  • 10. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
    Azijli K, Yuvaraj S, van Roosmalen I, Flach K, Giovannetti E, Peters GJ, de Jong S, Kruyt FA.
    Apoptosis; 2013 Jul 15; 18(7):851-60. PubMed ID: 23456625
    [Abstract] [Full Text] [Related]

  • 11. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
    Ray RM, Bhattacharya S, Johnson LR.
    Apoptosis; 2011 Jan 15; 16(1):35-44. PubMed ID: 20812030
    [Abstract] [Full Text] [Related]

  • 12. Oridonin synergizes with Nutlin-3 in osteosarcoma cells by modulating the levels of multiple Bcl-2 family proteins.
    Wang XH, Zhang SF, Bao JT, Liu FY.
    Tumour Biol; 2017 Jun 15; 39(6):1010428317701638. PubMed ID: 28618955
    [Abstract] [Full Text] [Related]

  • 13. Nutlin-3, a small-molecule MDM2 inhibitor, sensitizes Caki cells to TRAIL-induced apoptosis through p53-mediated PUMA upregulation and ROS-mediated DR5 upregulation.
    Park EJ, Choi KS, Yoo YH, Kwon TK.
    Anticancer Drugs; 2013 Mar 15; 24(3):260-9. PubMed ID: 23187459
    [Abstract] [Full Text] [Related]

  • 14. Wilms' tumor gene 1 enhances nutlin-3-induced apoptosis.
    Lee SY, Choe YJ, Park JY, Lee SS, Kim YH, Shin SJ, Chung YJ, Kim HS.
    Oncol Rep; 2014 Jan 15; 31(1):131-6. PubMed ID: 24190574
    [Abstract] [Full Text] [Related]

  • 15. The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells.
    Vaseva AV, Marchenko ND, Moll UM.
    Cell Cycle; 2009 Jun 01; 8(11):1711-9. PubMed ID: 19411846
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. DDTD, an isoflavone derivative, induces cell apoptosis through the reactive oxygen species/apoptosis signal-regulating kinase 1 pathway in human osteosarcoma cells.
    Chen JT, Fong YC, Li TM, Liu JF, Hsu CW, Chang CS, Tang CH.
    Eur J Pharmacol; 2008 Nov 12; 597(1-3):19-26. PubMed ID: 18822283
    [Abstract] [Full Text] [Related]

  • 18. MAPK/JNK1 activation protects cells against cadmium-induced autophagic cell death via differential regulation of catalase and heme oxygenase-1 in oral cancer cells.
    So KY, Kim SH, Jung KT, Lee HY, Oh SH.
    Toxicol Appl Pharmacol; 2017 Oct 01; 332():81-91. PubMed ID: 28782507
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Small molecule inhibition of HDM2 leads to p53-mediated cell death in retinoblastoma cells.
    Elison JR, Cobrinik D, Claros N, Abramson DH, Lee TC.
    Arch Ophthalmol; 2006 Sep 01; 124(9):1269-75. PubMed ID: 16966622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.